Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a clinically significant form of prostate cancer that can be treated with surgery, at a specific stage where the cancer has not spread to nearby lymph nodes or other parts of the body.
- People who are healthy enough to undergo a type of prostate removal surgery performed with robotic assistance.
- People whose medical team — based on MRI scans, biopsy results, and other clinical information — has recommended that a specific surgical technique (one that avoids cutting too close to the nerves near the prostate) be used on at least one side during the operation.
- People who are able to read English well enough to understand the participant information sheet and give their agreement to take part in the trial.
Who may not be able to join:
- People who have received hormone therapy (a treatment that lowers testosterone) before surgery.
- People whose MRI scan shows a very low likelihood that the cancer has grown beyond the prostate near the nerve bundles on the side of the prostate (confirm with trial site for exact scoring details).
- People whose MRI scan shows a high likelihood that the cancer has grown well beyond the prostate near the nerve bundles (confirm with trial site for exact scoring details).
- People whose scans show the cancer may have spread into the rectum or the seminal vesicles, where nerve-sparing surgery is considered unsafe from a cancer control perspective.
- People who have previously received any treatment for prostate cancer, including radiation therapy, internal radiation (brachytherapy), targeted local treatments (focal therapy), or chemotherapy.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Greg Shaw, Professor, University College, London
Phone: +44 02076792000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.